Skip to content

Regional Citrate Anticoagulation for acute intermittent hemodialysis versus saline flushing for safety, efficacy and effect on prolong life of blood circuit of hemodialysis machine; Randomized controlled trial

Regional Citrate Anticoagulation for acute intermittent hemodialysis versus saline flushing for safety, efficacy and effect on prolong life of blood circuit of hemodialysis machine; Randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200630004
Enrollment
300
Registered
2020-06-30
Start date
2020-06-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypocalcemia&#44

Interventions

regional citrate anticoagulation can successfully anticoagulated a hemodialysis circuit ,25 to 30 mL of saline flushes are administered every 15 to 30 minutes into the arterial (pre&#45
dialyzer) limb to minimize hemoconcentration and to wash out fibrin clots into the bubble trap.
Experimental Drug,Active Comparator Drug
regional citrate anticoagulation,routine saline flushing

Sponsors

Government
Lead Sponsor
Government
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients were eligible for enrollment if they were aged 18 years or older Patients with AKI requiring RRT, acute intermittent hemodialysis Contraindication to systemic anticoagulation or medium-to high bleeding risk during hemodialysis Informed consent

Exclusion criteria

Exclusion criteria: Patients were treated with antiplatelet &#44;oral anticoagulant therapy or other drugs known to affect coagulation within 7 days Acute liver failure or DIC Abnormal plasma total calcium < 7.0 mg/dL Documented arrhythmia Known allergy to citrate

Design outcomes

Primary

MeasureTime frame
Incidence of dialyzer clotting 30&#44; 60&#44; 120&#44;240 min after start regional citrate infusions Number of dialyzer clotting

Secondary

MeasureTime frame
Circuit survival time Time to first event of dialyzer clotting minute

Countries

Thailand

Contacts

Public ContactSirorat Waraaswapati

Bhumibol Adulyadej Hospital

wsiro@hotmail.com0911942959

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026